185 results on '"Kohli, Rohit"'
Search Results
2. Exposure to per- and polyfluoroalkyl substances and alterations in plasma microRNA profiles in children
3. Changes in plasma concentrations of per- and Polyfluoroalkyl substances after bariatric surgery in adolescents from the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study
4. Special Population: Pediatric Nonalcoholic Fatty Liver Disease
5. Effect of N‐acetyl cysteine in children with metabolic dysfunction‐associated steatotic liver disease—A pilot study.
6. Associations of dietary sugars with liver stiffness in Latino adolescents with obesity differ on PNPLA3 and liver disease severity.
7. Non-invasive biomarkers of Fontan-associated liver disease
8. Advances in management of end stage liver disease in children
9. Longitudinal Outcomes in Young Patients with Alpha-1-Antitrypsin Deficiency with Native Liver Reveal that Neonatal Cholestasis is a Poor Predictor of Future Portal Hypertension
10. Advocacy in pediatric gastroenterology: An academic clinician's impact and guide.
11. Vagal activation alters prandial bile acid composition and glycemia in patients with hypoglycemia after Roux‐en‐Y gastric bypass surgery.
12. Paediatric steatotic liver disease has unique characteristics: A multisociety statement endorsing the new nomenclature.
13. Hepatic Encephalopathy in Children.
14. Finance, race, ethnicity, and spoken language impact clinical outcomes for children with acute liver failure.
15. Exposure to per- and Polyfluoroalkyl Substances and Markers of Liver Injury: A Systematic Review and Meta-Analysis
16. Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease
17. Neurodevelopmental Outcome of Young Children with Biliary Atresia and Native Liver: Results from the ChiLDReN Study
18. In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis
19. Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children
20. Treatment of Inferior Vena Cava Obstruction Following Pediatric Liver Transplantation: Novel Use of a Customized Endovascular Stent
21. Rebaudioside affords hepatoprotection ameliorating sugar sweetened beverage- induced nonalcoholic steatohepatitis
22. Protein biomarkers GDF15 and FGF21 to differentiate mitochondrial hepatopathies from other pediatric liver diseases.
23. Lysophosphatidic acid receptor 1 antagonist (EPGN2154) causes regression of NASH in preclinical NASH models.
24. Sarcopenia is associated with osteopenia and impaired quality of life in children with genetic intrahepatic cholestatic liver disease.
25. Pediatric Nonalcoholic Fatty Liver Disease: A Report from the Expert Committee on Nonalcoholic Fatty Liver Disease (ECON)
26. Paired Liver:Plasma PFAS Concentration Ratios from Adolescents in the Teen-LABS Study and Derivation of Empirical and Mass Balance Models to Predict and Explain Liver PFAS Accumulation.
27. Effects of Dietary Sugar Reduction on Biomarkers of Cardiometabolic Health in Latino Youth: Secondary Analyses from a Randomized Controlled Trial.
28. Presence of Alpha 1 Antitrypsin Risk Variants is Not Associated With Histologic Severity of Pediatric NAFLD.
29. Increased glycine-amidated hyocholic acid correlates to improved early weight loss after sleeve gastrectomy
30. Bile acid metabolism and signaling: potential therapeutic target for nonalcoholic fatty liver disease
31. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids
32. Clinical spectrum and genetic causes of mitochondrial hepatopathy phenotype in children.
33. The role of the gut hormone GLP-1 in the metabolic improvements caused by ileal transposition
34. Dietary Management of Metabolic Liver Disease.
35. Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation.
36. The Evaluation of Hepatic Fibrosis Scores in Children with Nonalcoholic Fatty Liver Disease
37. FXR is a molecular target for the effects of vertical sleeve gastrectomy
38. GI multisociety strategic plan on environmental sustainability.
39. LET THE BILE FLOW!
40. Neurologic outcome of urea cycle disorder liver transplant recipients may be predicted by pretransplant neurological imaging
41. Evaluation of Fontan-associated Liver Disease and Ethnic Disparities in Long-term Survivors of the Fontan Procedure: A Population-based Study.
42. Impact of long‐term administration of maralixibat on children with cholestasis secondary to Alagille syndrome.
43. Effect of Guanylate Cyclase-C Activity on Energy and Glucose Homeostasis
44. Molecular insights from bariatric surgery
45. Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities
46. Duodenal nutrient exclusion improves metabolic syndrome and stimulates villus hyperplasia
47. IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice
48. Mixed lineage kinase 3 deficient mice are protected against the high fat high carbohydrate diet-induced steatohepatitis
49. Use of Magnetic Resonance Elastography to Assess Hepatic Fibrosis in Children with Chronic Liver Disease
50. Clinical Intervention to Reduce Dietary Sugar Does Not Affect Liver Fat in Latino Youth, Regardless of PNPLA3 Genotype: A Randomized Controlled Trial.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.